Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.

导出 OA

翻译打印收藏纠错

第一作者： Tianyu,Wu

第一单位： Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.

作者： Tianyu,Wu ^[1] ; Sichun,Zhou ^[2] ; Mei,Qin ^[3] ; Jing,Tang ^[1] ; Xinjian,Yan ^[1] ; Lingli,Huang ^[1] ; Meiyuan,Huang ^[4] ; Jun,Deng ^[2] ; Di,Xiao ^[2] ; Xin,Hu ^[2] ; Jingtao,Wu ^[2] ; Xiaoping,Yang ^[2] ; Gaofeng,Li ^[1]

作者单位： Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China. ^[1] Key Laboratory of Protein Chemistry and Developmental Biology of Fish of Ministry of Education, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy School of Medicine, Hunan Normal University, Changsha, China. ^[2] Department of Gynecologists, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China. ^[3] Department of Pathology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China. ^[4]

关键词 KU-55933 liver cancer mitochondria p-AMPK phenformin